Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
HIV services face cuts in worst hit areas

Support services for people living with HIV in South London are at risk of being cut, it has been revealed today. The proposed cuts to advice and counselling services will affect people living with HIV in Lambeth, Southwark and Lewisham, where HIV rates are soaring far above the national average.

Published
7 hours ago
From
Terrence Higgins Trust
With new data, states can better focus HIV prevention for gay, bisexual, and other men who have sex with men

HIV prevention for MSM has long been complicated by a lack of complete data.Now, Emory University researchers, in collaboration with CDC, have provided that crucial information Exit Disclaimer. The researchers estimated HIV rates for MSM in every state, and in most counties and cities nationwide.

Published
18 May 2016
From
aids.gov
Covering Costly HCV Tx: Who Makes that Call?

Forcing U.S. states to cover pricey treatments for people with the hepatitis C virus (HCV) would cause the Medicaid budget to "explode," according to a Medicaid representative.

Published
11 May 2016
From
MedPage Today HIV/AIDS
It’s Time to End Insurance Restrictions on Life-Saving Hepatitis C Treatments

As consensus on the shortsightedness of insurance restrictions on life-saving hepatitis C treatments continues to build, it’s time for private insurers and Medicaid programs to give all Americans suffering from this devastating disease a chance at a cure.

Published
10 May 2016
From
American Journal of Managed Care
Study: Cheaper to cure hepatitis C sooner than later

Although it would take a huge investment at the outset, treating hepatitis C patients could save $800 billion in the next 20 years and free up treatment for thousands of people with other liver disease.

Published
10 May 2016
From
UPI.com
A Way Out of the Dismal Arithmetic of Hepatitis C Treatment

This special issue of The American Journal of Managed Care presents important new peer-reviewed research about the consequences of this dismal arithmetic of HCV treatment. The papers cover ground ranging from the out-of-pocket costs of a DAA treatment course to the real-world consequences—both economic and clinical—of failing to treat.

Published
10 May 2016
From
American Journal of Managed Care
'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier

Merck & Co. has yet to report first-quarter earnings, so industry watchers still don’t know exactly how much market share the company’s new hep C combo treatment, Zepatier, has scored since winning approval in late January. But so far, comments from its competitors suggest it’s doing pretty well for itself.

Published
03 May 2016
From
Fierce Pharma
New York Insurers to Change Coverage of Hepatitis C Drugs

Seven health-insurance companies in New York will change their criteria for covering costly drugs that cure chronic hepatitis C under the terms of agreements with the office of State Attorney General Eric Schneiderman.

Published
26 April 2016
From
Wall Street Journal
HIV PrEP currently too pricey to justify use in people who inject drugs

The model suggested that over 20 years, enrolling a quarter of HIV uninfected injection drug users in a PrEP + screening + ART program would be the optimal approach for reducing HIV infection. However, at current drug prices this approach would cost the U.S. an additional $44 billion, which is equivalent to annually spending 10 percent of the current federal budget for domestic HIV/AIDS on PrEP for people who inject drugs.

Published
26 April 2016
From
Medical Xpress
Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV in Africa and Asia

The World Hepatitis Alliance welcomes the announcement of a new programme initiated by the Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares that aims to treat 10,000 co-infected HIV and hepatitis C patients in Africa and Asia with new hepatitis C treatment Daklinza (daclatasvir).

Published
14 April 2016
From
World Hepatitis Alliance
← First12345...87Next →

Filter by country